Krystal Biotech

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development of redosable gene therapies to improve the lives of patients living with rare diseases. The firm developed a proprietary gene delivery platform that enables off-the-shelf treatments for serious rare diseases with significant unmet need, initially in the areas of dermatology and respiratory diseases.

CEO

Krish S. Krishnan

CEOKrish S. Krishnan

Employees

119

Employees119

Headquarters

Pittsburgh, Pennsylvania

HeadquartersPittsburgh, Pennsylvania

Founded

2016

Founded2016

Employees

119

Employees119

KRYS Key Statistics

Market cap

1.78B

Market cap1.78B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

231.68K

Average volume231.68K

High today

$71.35

High today$71.35

Low today

$68.42

Low today$68.42

Open price

$71.34

Open price$71.34

Volume

175.77K

Volume175.77K

52 Week high

$102.99

52 Week high$102.99

52 Week low

$38.86

52 Week low$38.86

Analyst ratings

89%

of 9 ratings

Buy

88.9%

Hold

11.1%

Sell

KRYS Earnings

-$1.10

-$0.73

-$0.37

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 7, Pre-Market

ActualExpected Nov 7, Pre-Market